SVNT (Savient Pharmaceu)
All Pro Portfolios with SVNT
  • 1
  •     
  •  

People owning SVNT also tend to own:: DFJNPRORCLRVBDTOFTSCMYHOO

All Do-It-Yourself Portfolios with SVNT
  • News For Selected Stock
  • Related stories on theStreet.com
  • videos related to etf's
  • No videos found
  •  
  • blogs related to etf's
  • No blogs found
  •  

Why I Love This Stock

By:amcutler

Date:07 28 09

spec up over 100%

Not yet rated
Rate now:

By:Trading Nymph

Date:12 30 08

4

Not yet rated
Rate now:

By:mr1kimcpa

Date:04 10 08

long term

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Savient Pharma (SVNT) was upgraded from Neutral to Buy, Merrill Lynch said. $28 price target. Believe that positive Phase III data will lead to FDA approval for Puricase.

Not yet rated
Rate now:

By:Jacques Lemoyne

Date:11 04 07

New gout medication testing seems to be thumbs up. Only one of its kind. Should go on the market next year.

Not yet rated
Rate now:

By:goodferry

Date:10 08 07

Cramer

Not yet rated
Rate now:

By:TomK

Date:09 27 07

Have been buying dips since December 06. Learned about it via Cramer video. It's all about the Phase III trial being successful. I love it because its easy to know to buy the dips as long as there is no bad news about the Phase III trial.

Not yet rated
Rate now:

By:Norm Ajesty

Date:09 22 07

own

Not yet rated
Rate now:

By:bilken

Date:07 28 07

on technical

Not yet rated
Rate now:

By:Uncle Richard

Date:07 27 07

mm

Not yet rated
Rate now:

Why I Hate This Stock

By:LadyMoneyMagnet

Date:07 03 07

LOST MONEY

Not yet rated
Rate now:

By:Andrea2

Date:01 12 07

If you look at the details of this highly touted gout drug, Puricase, it's not impressive. It's administered as a 2h IV infusion every two weeks and is only indicated for patients have haven't responded to any other therapy. That doesn't sound like a big market to me. Puricase is just a pegylated protein, this is not innovative science.

Not yet rated
Rate now:
Add Your Comments  
Stock SVNT
Allowed HTML tags: <a><b><i><img>
  Login to post your comments
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 27, 2009 According to Jim Cramer, investors need to know the four enemies of all bull markets. On Wednesday’s “Mad Money” TV show...

11.27.09 | 13:36 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 27, 2009 According to CNBC’s “Fast Money” traders, the adjustment in the third-quarter GDP figure released on Tuesday from an exp...

11.27.09 | 12:22 PM
Black Friday Short-Squeeze Oppor...

By Jonas Elmerraji Posted on Nov. 25, 2009 With Thanksgiving fast approaching, retailers have one thing on their collective minds: Black Friday. After all, the day, whi...

11.25.09 | 13:33 PM
Dividend Stocks for the Week

By Jonas Elmerraji Posted on Nov. 24, 2009 Don’t dismiss dividends right now. While stocks may have made significant strides in the rally that’s taken hold of the m...

11.24.09 | 11:36 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Oprah Winfrey and the Bear Market
11.29.09 | 01:38 AM From author graspthemarket
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
The YouTube Exchange
07.22.09 | 17:45 PM From author Rawbrrt
more forums
Q. Regarding valuation analysis, Cr...
11.28.09 | 12:18 PM Asked by snassif

A. any forward growth guidance you get from
a company has to be taken with a grain
of salt. dubai was not news 2 days ago,
yesterday it clipped the s n p for 20
points. these are turbulent times and
all forward statements are a guess. 5
year ones are a joke. we've had a really
nice upternd for the last 8 months, that
may be coming to and end or at the very
least its probably gonna get choppy.
you're gonna have to be the judge of the
reliability of any future estimates and
any one stock can have multiple guesses
at theirs.

today 's lists
TheStreet.com TV Videos

These are some of the stocks mentioned on TheStreet.com TV recently. Click the URL below each stock to watch the videos. more

52-Week Highs

Here are some of the biggest stocks that made the 52-week high list on Nov. 27, 2009. more

Analyst Upgrades

Analyst Upgrades or Estimate Increases for Nov. 27, 2009. Read more here. more